Tanimoto Sarina sold SPRY

March 13, 2024 · Form 4 insider transaction

Tanimoto Sarina sold 1,500 shares of ARS Pharmaceuticals, Inc. at $9.00 per share, a transaction worth $13.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
1,500
Price
$9.00
Total value
$13.5K
RoleOfficer, 10% owner
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 13, 2024
Filing dateMarch 15, 2024
Shares owned after1,744,994
OwnershipIndirect
10b5-1 planYes
AmendedNo

Footnotes

The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023.; The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

View the original Form 4 on SEC EDGAR